Tie-2 activators targeting the Schlemm's canal
22 Feb 22
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta.
Filed: 28 Apr 20
Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)
23 Nov 21
The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.
Kevin Peters, Michael Allen Flynn
Filed: 17 Apr 20
Patents are sorted by USPTO publication date, most recent first